[French College of Gynecologists and Obstetricians (CNGOF) recommendations for clinical practice. Place of breast self-examination in screening strategies].

Date publication

août 2023

Journal

Gynecologie, obstetrique, fertilite & senologie

Auteurs

Membres identifiés du Cancéropôle Est :
Dr LUPORSI Elisabeth , Pr MATHELIN Carole , Dr MAUGARD Christine

Tous les auteurs :
Lavoué V, Favier A, Sophie F, Boutet G, Azuar AS, Brousse S, Golfier F, Uzan C, Vaysse C, Molière S, Boisserie-Lacroix M, Kermarrec E, Seror JY, Delpech Y, Luporsi É, Maugard CM, Taris N, Chabbert-Buffet N, Sabah J, Alghamdi K, Fritel X, Mathelin C

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/37652173

Résumé

Breast cancer is the most common female cancer in the world. In France, over 60,000 new cases are currently diagnosed, and 12,000 deaths are attributed to it annually. Numerous studies have shown that the risk of metastatic disease increases with tumor volume. In this context, it is useful to assess whether the regular practice of breast self-examination (BSE) has an impact on the number of cancers diagnosed, their stage, the treatments used and mortality.

Mots clés

auto-examen du sein, breast cancer, breast self-examination, cancer du sein, clinical examination, dépistage, examen clinique, palpation, screening

Référence

Gynecol Obstet Fertil Senol. 2023 08 29;: